首页 > 展会 > 2019中国南京第八届药物化学大会

2019中国南京第八届药物化学大会

发布时间:2019-02-26 17:24:26浏览:976
2019年11月15日 — 11月17日，南京，南京国际博览中心

展会名称：2019中国南京第八届药物化学大会

举办时间：2019-11-15 — 2019-11-17

举办展馆： 南京国际博览中心

主办单位：江苏省药学会

承办单位：百奥泰国际会议（大连）有限公司

协办单位：

行业分类： 医药保健

展会地区： 江苏 — 南京

展会简介

 
opening
 		 Stream 0: Main Conference
Part 1: Opening Ceremony
Part 2: Keynote Forum
Part 3: Dialog with Masters
 
Stream 1: Emerging Drug Targets
Session 101: Bioactive Lipids & Liposomes
Session 102: Human Kinases and Phosphatases
Session 103: G-protein Coupled Receptors(GPCR)& Ion-Channels
Session 104: Nuclear Receptor & Nucleic Acids
Session 105: Human Genome Derived Proteins
Session 106: Nanoparticles
 
 
 Stream 2: Drug Design and Screening
Session 201: Molecular Modeling and Drug Design
Session 202: Molecular Docking &Molecular Dynamics Simulations Studies
Session 203: Fragment-based Drug Design
Session 204: Computer-Aided Drug Design(CADD)
Session 205:QSAR/QSPR Modeling Methods
Session 206: High Throughput Screening(HTS)
Session 207: Combinatorial Chemistry
 
 
 Stream 3: Discovery of Lead Compounds
Session 301: Discovery of Lead Compounds by the Active Ingredients of Natural Products.
  •      Plant Sources
  •      Animal Sources
  •      Microbial Sources
  •      Marine Drug Sources
Session 302: The Synthesis of Derivatives
  • Synthesis Pyrimidine Derivatives
  • the Synthesis of Thiazole Derivatives
 
 
 Stream 4: Lead Compound Optimization and Structure Modification
 
Session 401: Leading Compound Structural Optimization Strategies to Improve Metabolic Stability by Altering Metabolic Pathways
Including
  • Blocking Metabolic Sites
  • Reducing Fat Solubility
  • Backbone Modification
  • Bioisosterism
  • Prodrugs
Session 402: Structural Modification Strategies to Reduce the Risk of Drug Toxicity
Including
  • Blocking Metabolic Sites
  • Changing Metabolic Pathways
  • Reducing Vigilance Structural Reactivity
  • Bioisosterism
  • Prodrugs
Session 403: Improve Water Solubility by Chemical Modification
Including
  • Blocking Metabolic Sites
  • Reducing Fat Solubility
  • Skeleton Modification
  • Bioisosterism
  • Prodrugs
Session 404: Several Commonly used Strategies to Improve the Permeability of Blood-Brain Barriers
include:
  • Increasing Fat Solubility
  • Reducing Hydrogen Bond Donors
  • Simplifying Molecules
  • Increasing Rigidity
  • Reducing Polar Surface Area
  • Removing Carboxyl Groups
  • Prodrugs
 
 

 		 Stream 5: New Technologies, New Processes for Drug Synthesis
Session 501: Research Status and Development Trends of Drug Synthesis Technology at Home and Abroad
  • Acoustic Chemical Synthesis
  • Microwave Chemical Synthesis
  • Electrochemical Synthesis
  • Solid Phase Reaction
  • Shock Wave Chemical Synthesis
 
Session 502: Research on New Synthetic Methods and Synthetic Processes of Drugs
  • Synthesis of Hybrid Compounds
  • Axial Ligand Synthesis
  • Biomimetic Synthesis
  • Stereoselective Chemistry
  • Heterocyclic Chemistry
  • Asymmetric Methods
Session 503: Technical Evaluation, Development and Optimization of Green Process Routes for Major Drug Varieties
Session 504: Application of New Catalysts in Drug Synthesis
Session 505: Chiral Synthesis Technology (Chemical Method, Biological Transformation Method)
Session 506: Control and Optimization of Drug Crystallization Process
Session 507: New Technologies and Applications for Drug Separation , Purification and Extraction Method
Session 508: Comprehensive Technical Treatment Plan for Three0waste Pollution
 
 

 		 Stream 6: ADMET in Medicinal Chemistry
Session 601: Pharmacology and Toxicology
Session 602: PK/PD Study in Medicinal Chemistry
Session 603: ADME Safety Assessment
 
 
 
 
 
 Stream 7: Next Generation Drug Pipelines
Session 701: New Anticancer Drugs
Session 702: Design, Synthesis and Biological Evaluation of Antibacterial and Antifungal Agents
Session 703: Drugs against Diabetes, Obesity and other Metabolic Disorders/Syndrome
Session 704: Drugs for Treating Central Nervous System Diseases& Antipsychotic
Session 705: Drug Therapy for Anti-Inflammatory and Immune Diseases
Session 706: Small Molecule Drugs for Tuberculosis and Malaria
Session 707: Drug Treatment Pain & AChE Inhibitors
Session 708: Next Generation Cardiovascular Drugs
 
 

 		 Stream 8: Macromolecular Medicinal Chemistry
Session 801: R&D of Macromolecular Drugs
  • Polypeptides
  • Proteins
  • Antibodies
  • Polysaccharides
  • Nucleic Acids
  • Vaccine
  • Growth Factor
  • Monoclonal Antibody
Session 802: Biomacromolecular Drug Targets
  • PD1
  • PD-L1
  • CTLA-4
  • LAG-3
Session 803: Biotechnology of Macromolecular Drugs
  • Genetic Engineering
  • Cell Engineering
  • Protein Engineering
  • Fermentation Engineering
Session 804: Macromolecular Drugs Therapy for Major Disease
  • AID/HIV
  • Tumor/ Cancer
  • Cardia-cerebrovascular Disease
  • Coronary heart disease/ CHD
  • Hepatitis
  • Multiple Sclerosis
  • Hemophilia
  • Hepatitis c
  • Cystic Fibrosis
  • Autoimmune Diseases
  • Rare Genetic Disease
 
 
 
 
 Stream 9: Showtime Square
Part 1: Papers and Posters
Part 2: Exhibition
 
 
 
opening
 		 Stream 0: Main Conference
Part 1: Opening Ceremony
Part 2: Keynote Forum
Part 3: Dialog with Masters
 
Stream 1: Emerging Drug Targets
Session 101: Bioactive Lipids & Liposomes
Session 102: Human Kinases and Phosphatases
Session 103: G-protein Coupled Receptors(GPCR)& Ion-Channels
Session 104: Nuclear Receptor & Nucleic Acids
Session 105: Human Genome Derived Proteins
Session 106: Nanoparticles
 
 
 Stream 2: Drug Design and Screening
Session 201: Molecular Modeling and Drug Design
Session 202: Molecular Docking &Molecular Dynamics Simulations Studies
Session 203: Fragment-based Drug Design
Session 204: Computer-Aided Drug Design(CADD)
Session 205:QSAR/QSPR Modeling Methods
Session 206: High Throughput Screening(HTS)
Session 207: Combinatorial Chemistry
 
 
 Stream 3: Discovery of Lead Compounds
Session 301: Discovery of Lead Compounds by the Active Ingredients of Natural Products.
  •      Plant Sources
  •      Animal Sources
  •      Microbial Sources
  •      Marine Drug Sources
Session 302: The Synthesis of Derivatives
  • Synthesis Pyrimidine Derivatives
  • the Synthesis of Thiazole Derivatives
 
 
 Stream 4: Lead Compound Optimization and Structure Modification
 
Session 401: Leading Compound Structural Optimization Strategies to Improve Metabolic Stability by Altering Metabolic Pathways
Including
  • Blocking Metabolic Sites
  • Reducing Fat Solubility
  • Backbone Modification
  • Bioisosterism
  • Prodrugs
Session 402: Structural Modification Strategies to Reduce the Risk of Drug Toxicity
Including
  • Blocking Metabolic Sites
  • Changing Metabolic Pathways
  • Reducing Vigilance Structural Reactivity
  • Bioisosterism
  • Prodrugs
Session 403: Improve Water Solubility by Chemical Modification
Including
  • Blocking Metabolic Sites
  • Reducing Fat Solubility
  • Skeleton Modification
  • Bioisosterism
  • Prodrugs
Session 404: Several Commonly used Strategies to Improve the Permeability of Blood-Brain Barriers
include:
  • Increasing Fat Solubility
  • Reducing Hydrogen Bond Donors
  • Simplifying Molecules
  • Increasing Rigidity
  • Reducing Polar Surface Area
  • Removing Carboxyl Groups
  • Prodrugs
 
 

 		 Stream 5: New Technologies, New Processes for Drug Synthesis
Session 501: Research Status and Development Trends of Drug Synthesis Technology at Home and Abroad
  • Acoustic Chemical Synthesis
  • Microwave Chemical Synthesis
  • Electrochemical Synthesis
  • Solid Phase Reaction
  • Shock Wave Chemical Synthesis
 
Session 502: Research on New Synthetic Methods and Synthetic Processes of Drugs
  • Synthesis of Hybrid Compounds
  • Axial Ligand Synthesis
  • Biomimetic Synthesis
  • Stereoselective Chemistry
  • Heterocyclic Chemistry
  • Asymmetric Methods
Session 503: Technical Evaluation, Development and Optimization of Green Process Routes for Major Drug Varieties
Session 504: Application of New Catalysts in Drug Synthesis
Session 505: Chiral Synthesis Technology (Chemical Method, Biological Transformation Method)
Session 506: Control and Optimization of Drug Crystallization Process
Session 507: New Technologies and Applications for Drug Separation , Purification and Extraction Method
Session 508: Comprehensive Technical Treatment Plan for Three0waste Pollution
 
 

 		 Stream 6: ADMET in Medicinal Chemistry
Session 601: Pharmacology and Toxicology
Session 602: PK/PD Study in Medicinal Chemistry
Session 603: ADME Safety Assessment
 
 
 
 
 
 Stream 7: Next Generation Drug Pipelines
Session 701: New Anticancer Drugs
Session 702: Design, Synthesis and Biological Evaluation of Antibacterial and Antifungal Agents
Session 703: Drugs against Diabetes, Obesity and other Metabolic Disorders/Syndrome
Session 704: Drugs for Treating Central Nervous System Diseases& Antipsychotic
Session 705: Drug Therapy for Anti-Inflammatory and Immune Diseases
Session 706: Small Molecule Drugs for Tuberculosis and Malaria
Session 707: Drug Treatment Pain & AChE Inhibitors
Session 708: Next Generation Cardiovascular Drugs
 
 

 		 Stream 8: Macromolecular Medicinal Chemistry
Session 801: R&D of Macromolecular Drugs
  • Polypeptides
  • Proteins
  • Antibodies
  • Polysaccharides
  • Nucleic Acids
  • Vaccine
  • Growth Factor
  • Monoclonal Antibody
Session 802: Biomacromolecular Drug Targets
  • PD1
  • PD-L1
  • CTLA-4
  • LAG-3
Session 803: Biotechnology of Macromolecular Drugs
  • Genetic Engineering
  • Cell Engineering
  • Protein Engineering
  • Fermentation Engineering
Session 804: Macromolecular Drugs Therapy for Major Disease
  • AID/HIV
  • Tumor/ Cancer
  • Cardia-cerebrovascular Disease
  • Coronary heart disease/ CHD
  • Hepatitis
  • Multiple Sclerosis
  • Hemophilia
  • Hepatitis c
  • Cystic Fibrosis
  • Autoimmune Diseases
  • Rare Genetic Disease
 
 
 
 
 Stream 9: Showtime Square
Part 1: Papers and Posters
Part 2: Exhibition
 
 
Joint Events-1
 		 Stream 10: Joint Events
Event 1 : BIT's 17th Annual Congress of International Drug Discovery Science and Technology-China
Event 2 : BIT's 9th Annual Symposium of Drug Delivery Systems
Event 3 : BIT's 1st Annual World Congress of  Microbiome
Event 4 : BIT's 1st World Congress of Medical Imaging
 
 
Joyful Commune B
 		 Stream 11: Joyful Commune
Activity 1: Pre-conference Ice-Breaking Party
Activity 2: Welcome Banquet and Art Performance
Activity 3: Industrial Sponsored Cocktail Party
Activity 4: Lecture Tours to Campus
Activity 5: Field Trip to Industrial Park and Companies
Activity 6: Local Cultural Tours
 
 
 		 Stream 10: Joint Events
Event 1 : BIT's 17th Annual Congress of International Drug Discovery Science and Technology-China
Event 2 : BIT's 9th Annual Symposium of Drug Delivery Systems
Event 3 : BIT's 1st Annual World Congress of  Microbiome
Event 4 : BIT's 1st World Congress of Medical Imaging
 
 
Joyful Commune B
 		 Stream 11: Joyful Commune
Activity 1: Pre-conference Ice-Breaking Party
Activity 2: Welcome Banquet and Art Performance
Activity 3: Industrial Sponsored Cocktail Party
Activity 4: Lecture Tours to Campus
Activity 5: Field Trip to Industrial Park and Companies
Activity 6: Local Cultural Tours
 
 

参展范围

药物化学方向

参展费用

联系方式

联系我时请说明是在展会吧看到的，这样会有优惠哦，谢谢！
Tel: 0086-0411-84799609-819
Email: sylvia@bit-conference.com
Email: mandy@iddst-china.com
上一页：2019第20届山东国际加盟连锁展4月相约济南
下一页：被誉为亚洲三大电池展之一的第十一届中国（上海）国际锂电工业展览会(CNIBF2019)将于2019年8月28-30日在上海新国际博览中心举办

推荐展会

您可能感兴趣的展会